Video
ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
EURO-SKI: 46% of CML patients still in molecular recurrence- and treatment-free ...
Prof Francois-Xavier Mahon - University of Bordeaux, Bordeaux, France
Clinical utility of molecular tumour profiling in breast cancer
Prof Fabrice André - Gustave Roussy, Paris, France
Real world data supports ciltacabtagene autoleucel as effective option for tripl...
Dr Maria-Victoria Mateos - University Hospital of Salamanca-IBSAL, Salamanca, Sp...
Dara-CVRd, V-ASCT and Dara-Vrd Consolidation in UHiR NDMM and pPCL compared with...
Dr Martin Kaiser - The Institute of Cancer Research, London UK
Monoclonal antibody-based quadruplet therapy, AHCT and MRD response-adapted cons...
Prof Luciano Costa - University of Alabama at Birmingham, Birmingham, USA
Latest in combination therapy for NDMM patients
Prof Luciano Costa - University of Alabama at Birmingham, Birmingham, USA
Lenalidomide and rituximab as front-line chemo-free therapy for elderly frail pa...
Dr Guido Gini - Università Politecnica delle Marche, Ancona, Italy
Antibody and T-cell responses to COVID-19 vaccination in myeloproliferative neop...
Dr Chi-Joan How - Brigham and Women's Hospital, Boston, USA
Allogeneic CAR-T PBCAR0191 with intensified lymphodepletion is highly active in ...
Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA
Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma
Prof Ryan Lynch - University of Washington School of Medicine, Seattle, USA
ZUMA-12: A phase 2 study of axi-cel as first-line therapy in patients with high-...
Prof Sattva Neelapu - The University of Texas MD Anderson Cancer Center, Houston...
Potentially targetable pathways ID’d for augmenting CAR-T cell therapy for DLBCL
Prof Brian Hill - Cleveland Clinic, Cleveland, USA